US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules

Reason CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Breckenridge Pharmaceutical, Inc. NDC 82009-032-10 D-0215-2026
Class III · Low risk Ongoing

Bisoprolol Fumarate and Hydrochlorothiazide Tablets

Reason Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe

Glenmark Pharmaceuticals Inc., USA D-0199-2026
Class III · Low risk Ongoing

Nebivolol Tablets

Reason Cross Contamination with Other Products

Glenmark Pharmaceuticals Inc., USA NDC 42291-874-90 D-0222-2026
Class II · Moderate risk Ongoing

Ondansetron ODT Tablets

Reason Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Preferred Pharmaceuticals, Inc. NDC 68788-8666-01 D-0239-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0226-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0225-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0224-2026
Class II · Moderate risk Ongoing

Ganirelix Acetate Injection

Reason Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Lupin Pharmaceuticals Inc. NDC 70748-274-01 D-0220-2026
Class II · Moderate risk Ongoing

Walgreens Saline Nasal Spray WITH XYLITOL

Reason Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis

Medical Products Laboratories, Inc. NDC 0363-3114-01 D-0179-2026
Class III · Low risk Ongoing

Varenicline Tablets

Reason Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

Dr. Reddy's Laboratories, Inc. NDC 43598-908-56 D-0219-2026
Class III · Low risk Ongoing

Carton label: Testosterone Gel 1%

Reason Defective Container - A defect in the side-seal which allows leakage of product.

Teva Pharmaceuticals USA, Inc NDC 0591-3216-30 D-0198-2026
Class I · High risk Ongoing

Famotidine Injection

Reason Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Fresenius Kabi USA, LLC NDC 63323-739-11 D-0182-2026
Class II · Moderate risk Ongoing

Sertraline Hydrochloride Tablets USP

Reason Defective container - seal not adhering to bottles

Lupin Pharmaceuticals Inc. NDC 68180-353-09 D-0227-2026
Class II · Moderate risk Ongoing

OraVerse

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 0362-0101-10 D-0234-2026
Class II · Moderate risk Ongoing

Cook-Walte

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 0362-0753-05 D-0233-2026
Class II · Moderate risk Ongoing

Benco dental Graham CHEMICAL CO.

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66975-406-51 D-0232-2026
Class II · Moderate risk Ongoing

darby dental supply

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk Ongoing

3% Polocaine DENTAL

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026
Class II · Moderate risk Ongoing

Lidocaine HCI 2% and Epinephrine 1:100

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 50227-1030-5 D-0229-2026
Class II · Moderate risk Ongoing

2% Xylocaine DENTAL with Epinephrine 1:100

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66312-176-16 D-0228-2026
Class II · Moderate risk Ongoing

Wecare Calasoothe

Reason cGMP deviations

Blossom Pharmaceuticals NDC 67777-234-04 D-0213-2026
Class II · Moderate risk Ongoing

Globe Clotrimazole Cream USP

Reason cGMP deviations

Blossom Pharmaceuticals NDC 69396-087-55 D-0211-2026
Class II · Moderate risk Ongoing

Globe Clotrimazole Cream

Reason cGMP deviations

Blossom Pharmaceuticals NDC 69396-087-01 D-0210-2026